# Caspofungin Study for Fungal Infections in Adults in Critical Care Settings

> **NCT00095316** · PHASE3 · TERMINATED · sponsor: **National Institute of Allergy and Infectious Diseases (NIAID)** · enrollment: 1200 (estimated)

## Conditions studied

- Candidiasis

## Interventions

- **DRUG:** Caspofungin
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT00095316
- **Lead sponsor:** National Institute of Allergy and Infectious Diseases (NIAID)
- **Sponsor class:** NIH
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2004-10
- **Primary completion:** —
- **Final completion:** 2006-09
- **Target enrollment:** 1200 (ESTIMATED)
- **Last updated:** 2014-12-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00095316

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00095316, "Caspofungin Study for Fungal Infections in Adults in Critical Care Settings". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00095316. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*